SeaView Research   Report issue

For profit Phase 1
Founded: Miami FL United States (1995)
Status: Acquired by Quotient (2017) → now Pharmaron (2016)

Organization Overview

First Clinical Trial
2008
NCT00685906
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

SeaView Research, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 1)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

HIV Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 8